Increased blood-brain barrier permeability is associated with dysfunctional α band connectivity in early-stage Parkinson's disease

Comprehensive Summary

This study, conducted by Conti et al., explores the relationship between deficiencies in the blood-brain barrier (BBB) and cortico-cortical functional connectivity (FC) in patients with early-stage Parkinson’s disease by using the Albumin Index (Qalb) to measure BBB permeability. This study utilized high-density electroencephalography (HD-EEG) to record EEG data and network-based statistics (NBS) in combination with machine learning (ML) to analyze data. FC between 68 patients with early-stage Parkinson’s and 62 healthy controls were compared using NBS in combination with optimized non-linear ML, and the Qalb data was analyzed using this novel method as well. In this study, it was found that Qalb had little correlation with neurodegenerative markers, but prior research has found higher Qalb measurements in diseased patients compared to healthy patients. The results showed that FC differences between healthy patients and diseased patients varied by band. In the α band, there was decreased FC in patients with Parkinson’s compared to healthy patients, while in the β band, there was increased FC. Decreased FC in the α band was found to be linked to deficits in motor and cognitive function, while increased FC in the β band was found to be linked to bradykinesia. In the limbic, prefrontal, and temporal regions, a negative correlation was found between higher Qalb values and the EEG-FC in the α band.

Outcomes and Implications

The timeline of BBB compromise and the progression of Parkinson’s disease is unclear, and this research study aimed to further investigate this relationship. Moreover, a novel approach to analyzing data, combining NBS with optimized non-linear ML, was proposed for further studies due to its ability to process large-scale data and complex relationships regarding neurodegenerative markers. This could advance comprehension of neurodegenerative disease onsets, improve early diagnoses, and allow for more effective treatments. This study was observational and only involved patients with early-stage Parkinson’s disease, so further research should be conducted in order to solidify and expand on these findings.